Literature DB >> 33061502

Metabolic Syndrome and Incident Asthma in Chinese Adults: An Open Cohort Study.

Haixia Wang1, Chenxiao Bai1, Mo Yi1, Yuanmin Jia1, Yizhang Li1, Di Jiang1, Ou Chen1.   

Abstract

BACKGROUND: Although metabolic syndrome is awell-known risk factor for many non-communicable diseases, its contribution to asthma remains controversial.
OBJECTIVE: The aim of this study was to explore the associations of metabolic syndrome and its components with incident asthma in Chinese adults.
METHODS: We conducted an open cohort study of participants who were asthma-free at baseline (n=42,304) in the Shandong multi-center health check-up longitudinal study from 2004 to 2015. Participants aged ≥20 years and had regular physical examination (once ayear) more than three times during follow-up.
RESULTS: Ninety subjects (38 women and 52 men) developed incident asthma over 12 years of follow-up. Our study suggested that metabolic syndrome itself was not significantly associated with incident asthma in either women or men (P>0.050). Interestingly, we found that overweight and/or obesity was arisk factor for incident asthma among women but not men in the Cox proportional hazards model after adjusting covariates (adjusted incidence rate ratio (IRR)= 2.940, 95% confidence interval (CI): 1.467-5.894, P=0.002). The result was consistent with the Poisson regression model (hazard ratio (HR)= 2.241, 95% CI: 1.135-4.988, P=0.026). After stratifying according to overweight and/or obesity, we found that female subjects with overweight and obesity were associated with the occurrence of incident asthma (P<0.050). However, we did not find this result among men.
CONCLUSION: Metabolic syndrome was not significantly associated with incident asthma in both women and men; however, overweight and/or obesity was shown to be asignificant risk factor for incident asthma but only in women, not in men.
© 2020 Wang et al.

Entities:  

Keywords:  incident asthma; metabolic syndrome; overweight and/or obesity; risk factor

Year:  2020        PMID: 33061502      PMCID: PMC7532911          DOI: 10.2147/DMSO.S274159

Source DB:  PubMed          Journal:  Diabetes Metab Syndr Obes        ISSN: 1178-7007            Impact factor:   3.168


Introduction

Asthma is achronic inflammatory disease caused by gene–environment interactions, with symptoms of wheezing, coughing, chest tightness, and shortness of breath.1 Prevalence rates for asthma have been increasing in many countries over the past few decades.2–4 Approximately 235million people worldwide suffer from asthma.5 Asthma has become one of the most common diseases in the world, resulting in asubstantial disease burden.6 Therefore, it is particularly important to prevent asthma by identifying risk factors for asthma, such as smoking, allergic rhinitis, eczema, psychosocial factors, rhinitis, sinusitis, lung infections, alcohol consumption, air pollution and occupational exposure.7–10 Overweight and/or obesity is avast public health problem and amajor risk factor for asthma in adults.11,12 Overweight and/or obesity is considered part of the metabolic syndrome in China.13 Metabolic syndrome is awell-known cluster of cardiometabolic risk factors associated with an increased risk of multiple chronic diseases, including cancer and cardiovascular disease, and is associated with an approximately 2-fold higher risk of cardiovascular disease and a5-fold or more increase in the risk of type 2 diabetes mellitus.14–16 In addition, metabolic syndrome is associated with lung function impairment.17–19 More recently, literature has emerged that offers contradictory findings of the epidemiological link between metabolic syndrome and asthma.20–23 Prior studies that have noted that metabolic syndrome and its components (high waist circumference (WC), lower high-density lipoprotein cholesterol (HDL-C) and elevated glucose, insulin resistance (IR) or diabetes) were associated with an increased risk of asthma.22,23 However, some evidence suggested that metabolic syndrome predicted incident asthma among women but not men.20 In addition, surveys such as that conducted by Tomita etal21 have shown that metabolic syndrome was not arisk factor for the incidence of late-onset asthma. However, whether metabolic syndrome was arisk factor for asthma was not known in the Chinese population. Based on this, our study aimed to explore the relationship between metabolic syndrome and its components and incident asthma in Chinese adults.

Methods

Study Design

This was an open cohort study that the original participants exited continuously and new objects joined at any time, covering more than 20 health management centres in Shandong Province from January2004 to December2015. The longitudinal observational study included 76,368 participants who were free from asthma at baseline, covering nearly all of Shandong Province.24 The study design and age distribution of this population are shown in Figures 1 and 2. The study was approved by the Institutional Ethical Committee, School of Nursing, Cheeloo College of Medicine, Shandong University (2003-R-036). The study was in compliance with the Declaration of Helsinki for clinical research. All participants provided written informed consent before participating in the study.
Figure 1

Age distribution of the population.

Figure 2

Study design.

Age distribution of the population. Study design. The research data were obtained through questionnaire surveys, healthy physical measurements and laboratory examinations of the participants. The questionnaire survey included age, gender, disease history, drinking status and smoking status. Physical measurement indicators included height, weight, systolic blood pressure (SBP) and diastolic blood pressure (DBP). Laboratory indicators included fasting plasma glucose (FPG), triglycerides (TGs), and HDL-C, etc. Height and weight were measured with light clothing without shoes; BP was measured using Omron HEM-907 by the cuff-oscillometric method on the right arm in sitting position after a5-min rest, and the mean SBP and DBP values of two measurements were recorded, respectively. In addition, participants needed fasting for more than 12 h. In the follow-up, we collected asthma-related diseases (rhinitis, nasal polyps, pneumonia, bronchiectasis, pulmonary infection, bronchitis, and Chronic obstructive pulmonary disease (COPD)), these diseases were self-reported by participants, including nasal polyps. The doctor at the medical center also confirmed the diagnosis based on the patient’s symptoms and related laboratory tests, because nasal polyps coexist with sinusitis.25 In this study, nasal polyps were only nasal polyps without accompanying sinusitis.

Inclusion and Exclusion Criteria

The inclusion criteria were as follows: 1) participants aged ≥20 years; 2) participants had regular physical examination (once ayear) more than three times during follow-up; 3) participants in the study who did not have asthma at baseline diagnosed by doctors at the Health Management Center; and 4) individuals who provided informed consent to participate voluntarily. The exclusion criteria were as follows: missing indicators related to metabolic syndrome at baseline (height, weight, SBP, DBP, FPG, TGs, and HDL-C). Finally, this study included 42,304 subjects. The median follow-up time was 3.1 years.

Dependent and Independent Variables

The primary dependent variable was physician-diagnosed asthma during the annual physical examination. The diagnostic criteria for asthma were according to the guidelines for Asthma Section, Respiratory Disease Branch, Chinese Medical Association26 (). The primary independent variable was metabolic syndrome, including four components. The diagnosis of metabolic syndrome was made using the criteria recommended by the Chinese Medical Association Diabetes Division (CDS) in 2004:27 1) overweight and/or obesity: BMI ≥25.0kg/m2; 2) hyperglycaemia: FPG ≥6.1 mmol/L (110mg/dL), 2hPG ≥7.8 mmol/L (140mg/dL), and/or diagnosis of and treatment for diabetes; 3) hypertension: SBP/DBP ≥140/90 mmHg and/or confirmation and treatment of hypertension; 4) TGs ≥1.7 mmol/L (150mg/dL) and/or HDL-C <0.9 mmol/L (35mg/dL) (male) or <1.0 mmol/L(39mg/dL) (female). Metabolic syndrome was diagnosed when 3 or more of the above 4 components met the criteria.

Statistical Analysis

Considering that studies have shown that the relationship between metabolic syndrome and asthma is different between men and women, we divided the participants into two groups of men and women for analysis.20 Acomparison of baseline characteristics (age, sex, BMI, smoking status, drinking status and some respiratory diseases) between participants included and excluded from this cohort study was performed by the chi-square test for categorical variables and the Wilcoxon rank sum test for continuous variables. Multiple analyses were performed using the Cox proportional hazards model to determine the association between metabolic syndrome and its components and incident asthma. Considering the low incidence of asthma in this study, we also performed Poisson regression model to verify the reliability of the results. We included metabolic syndrome and the components of metabolic syndrome in model 1 and model 2, respectively, and adjusted the three covariates of age, drinking and smoking status. Then, statistically significant variables such as overweight and/or obesity and other statistically significant variables in univariate analysis were simultaneously entered into the statistical models to compare the impact of those factors on the outcome; Considering that significant lung diseases might affect our findings, we further excluded participants who diagnosed COPD at follow-up (n=184). The excluded data were also included in the two models for analysis. In addition, we also included participants with BMI data but not included in this study into the Poisson regression and Cox proportional hazards model for statistical analysis. We further included stratification of overweight and obesity into the model for analysis. The statistical significance threshold of IRRs and 95% CIs was P<0.05. All analyses were performed using IBM SPSS Statistics 24.

Results

Identification and Characteristics of the Participants

Among the 76,368 original participants at the baseline examination in the open cohort, 42,304 eligible subjects were included in the study (Figure 3). Ninety eligible subjects developed incident asthma during the follow-up, including 38 women (42.22%) and 52 men (57.78%). Compared to the excluded participants, included participants exhibited different demographic characteristics, generally lower age, more women, less smoking, less drinking and less asthma-like respiratory diseases ().
Figure 3

Overview of study participant.

Overview of study participant.

Characteristics of the Participants

As shown in Table 1, we found that older individuals, drinker (people who are drinking or used to drink), smokers (people who are smoking or have smoked), people with higher DBP or those who had respiratory diseases (nasal polyps, pneumonia, bronchitis, COPD, bronchiectasis) were more likely to develop incident asthma among men. In addition, the results showed that people who were older, had higher TGs, were overweight and/or obese, and had incident respiratory diseases (pneumonia, bronchitis, COPD, bronchiectasis) were more likely to develop incident asthma among women.
Table 1

Characteristics of 42,304 Participants Included in the Study

CharacteristicsMen (26,009)Women (16,295)
Asthma(n=52) Control(n=25,957) Pvalue Asthma(n=38) Control(n=16,257) Pvalue 
Age, years46.67(11.43)42.25(12.57)0.00*47.71(10.95)43.22(13.32)0.01*
BMI,kg/m2 25.49(3.48)25.78(3.51)0.5523.77(3.24)23.47(3.57)0.55
SBP133.21(21.23)130.44(17.08)0.31120.82(17.05)120.68(18.92)0.96
DBP83.94(10.13)81.29(12.32)0.04*74.66(10.67)72.84(11.56)0.26
HDL-C52.12(13.14)49.69(11.25)0.1357.27(11.95)56.57(11.79)0.71
TGs160.09(100.93)158.06(147.73)0.88116.78(66.13)102.05(80.82)0.04*
FPG100.24(16.66)99.08(25.39)0.5893.47(10.30)94.44(20.26)0.60
BMI
 <25kg/m226(50.00)10,760(41.45)18(47.37)10,498(64.58)
 ≥25kg/m2 26(50.00)15,197(58.55)0.2120(52.63)5759(35.42)0.03*
HDL-C
 ≥35mg/dl(male)/≥39mg/dl(female)49(94.23)24,454(94.21)36(94.94)15,534 (95.55)
 <35mg/dl(male)/<39mg/dl(female)3(5.77)1503(5.79)1.002(5.26)723(4.55)0.81
TGs
 <150mg/dl30(57.69)16,653(64.16)28(73.68)13,760(84.64)
 ≥150mg/dl22(42.31)9340(35.98)0.3310(26.32)2497 (15.36)0.07
FPG
 <110mg/dl41(78.85)22,114(85.19)36(94.94)15,534 (95.55)
 ≥110mg/dl11 (21.15)3843 (14.81)0.202(5.26)723(4.55)0.38
BP
 <140/90mmHg32 (61.54)17,587 (67.75)32(84.21)13,565(83.44)
 ≥140/90mmHg20 (38.46)8370 (32.25)0.346(15.79)2692(16.56)0.90
 History of hypertension7 (13.46)2258 (8.70)0.233 (7.89)995 (6.12)0.65
 History of diabetes1 (1.92)830 (3.20)0.610(0.00)395 (100.00)
 Metabolic Syndrome10 (19.23)4830 (18.61)0.912 (5.26)1177 (7.24)0.64
 Drinking status22(42.31)6681(25.74)0.01*0(0.00)41(0.25)/
 Smoking status19 (36.54)5349 (20.61)0.01*0(0.00)0 (0.00)/
Componentsofmetabolicsyndrome   
 Overweight or obesity26(50.00)15,197(58.55)0.2120(52.63)5759(35.42)0.03*
 Hyperglycemia12 (23.08)3943 (15.19)0.122(5.26)1609 (9.90)0.35
 Hypertension20 (38.46)8832 (34.03)0.507(18.42)2963(18.23)0.98
 Dyslipidemia22 (42.31)9783 (37.69)0.4911(28.95)2837(17.45)0.07
Respiratory diseases
 Rhinitis1 (1.92)97 (0.37)0.100(0.00)28(0.00)/
 Nasal polyps1 (1.92)41 (0.16)0.01*0(0.00)11(0.00)/
 Pulmonary infection1 (1.92)119 (0.46)0.152(5.26)82(0.50)0.00*
 Pneumonia7 (13.46)308 (1.19)0.00*7(18.42)198(0.01)0.00*
 Bronchitis8 (15.38)313 (1.21)0.00*10(26.32)236(0.02)0.00*
 COPD7 (13.46)95 (0.37)0.00*3(7.89)23(0.00)0.00*
 Bronchiectasis1 (1.92)39(0.15)0.01*1(2.63)23(0.001)0.00*

Note: *P<0.05.

Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; TGs, triglycerides; FPG, fasting plasma glucose; COPD, chronic obstructive pulmonary disease; IRR, incident rate ratios.

Characteristics of 42,304 Participants Included in the Study Note: *P<0.05. Abbreviations: BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; TGs, triglycerides; FPG, fasting plasma glucose; COPD, chronic obstructive pulmonary disease; IRR, incident rate ratios.

Relationship Between Metabolic Syndrome and Its Components and Incident Asthma

The associations of metabolic syndrome and its components with incident asthma are shown in Table 2. Metabolic syndrome could not predict incident asthma in men and women after adjusting for age, drinking and smoking status (P>0.05) in model 1. Of the four metabolic syndrome components, only the associations for overweight or/and obesity remained relatively stable after adjustment for all covariates among women (P<0.05) in model 2. However, this result was not found among men. We also used the Poisson regression model for analysis, and the analysis results were similar in the Cox proportional hazard model analysis (). The relationship between overweight and/or obesity and incident asthma was statistically significant after adjusting for and unadjusted covariates (age, smoking and drinking status) (Table 3, ).
Table 2

Longitudinal Associations Between the Metabolic Syndrome and Incident Asthma

Statistical ModelsMenWomen
HR (95% CI)PHR (95% CI)P
Mode l
 Metabolic syndrome+0.81(0.40–1.63)0.560.45(0.10–1.95)0.29
 Metabolic syndrome-0.92(0.46–1.83)0.810.82(0.20–3.40)0.78
Model 2
 Hypertension+0.87(0.48–1.60)0.660.55(0.22–1.35)0.19
 Dyslipidemia+1.06(0.59–1.90)0.841.23(0.58–2.58)0.59
 Hyperglycemia+1.42(0.73–2.79)0.310.37(0.09–1.61)0.19
 Overweight and/or obesity+0.77(0.43–1.37)0.372.94(1.47–5.89)0.00*
 Hypertension-1.03(0.57–1.85)0.920.76(0.32–1.80)0.53
 Dyslipidemia-1.04(0.58–1.86)0.901.36(0.65–2.86)0.42
 Hyperglycemia-1.70(0.87–3.30)0.120.45(0.11–1.94)0.29
 Overweight and/or obesity-0.76(0.42–1.35)0.353.54(1.79–7.01)0.00*

Notes: +Adjusted age, smoking and drinking status; -unadjusted age, smoking and drinking status. * P<0.05.

Abbreviations: HR, hazard ratio; IRR, incident rate ratios.

Table 3

Longitudinal Associations Between Overweight and/or Obesity and Incident Asthma

Statistical ModelsMenWomen
HR (95% CI)PHR (95% CI)P
BMI-
 <25kg/m2
 ≥25kg/m2 1.61(0.33–7.74)0.566.86(1.84–25.58)0.00*
BMI+
 <25kg/m2
 ≥25kg/m2 0.96(0.18–5.15)0.975.05(1.26–20.22)0.02*

Notes: +Adjusted age, smoking and drinking status; -unadjusted age, smoking and drinking status. *P<0.05.

Abbreviations: HR, hazard ratio; IRR, incident rate ratios; BMI, body mass index.

Longitudinal Associations Between the Metabolic Syndrome and Incident Asthma Notes: +Adjusted age, smoking and drinking status; -unadjusted age, smoking and drinking status. * P<0.05. Abbreviations: HR, hazard ratio; IRR, incident rate ratios. Longitudinal Associations Between Overweight and/or Obesity and Incident Asthma Notes: +Adjusted age, smoking and drinking status; -unadjusted age, smoking and drinking status. *P<0.05. Abbreviations: HR, hazard ratio; IRR, incident rate ratios; BMI, body mass index. After stratifying by overweight and obesity, we found that overweight and obesity were associated with the occurrence of incident asthma among women (P<0.05). However, we did not find this result among men (Table 4). We used the Poisson regression model for analysis, and the analysis results were similar in the Cox proportional hazard model analysis (). The Characteristics of participants with BMI data but excluded in the study in . We also verified this result in excluded population including women () and men ().
Table 4

Longitudinal Associations Between BMI and Incident Asthma

VariablesMenWomen
HR (95% CI)PHR (95% CI)P
BMI 25.0–29.9kg/m2 -0.813(0.461–1.435)0.483.194(1.593–6.404)0.001*
BMI≥30kg/m2-0.783(0.276–2.275)0.678.134(3.126–21.168)0.000*
BMI 25.0–29.9kg/m2 +0.784(0.443–1.387)0.402.711(1.310–5.610)0.007*
BMI≥30kg/m2+0.769(0.268–2.211)0.636.405(2.339–17.541)0.000*

Notes: +Adjusted age, smoking and drinking status; -unadjusted age, smoking and drinking status. *P<0.05.

Abbreviations: HR, hazard ratio; IRR, incident rate ratios; BMI, body mass index.

Longitudinal Associations Between BMI and Incident Asthma Notes: +Adjusted age, smoking and drinking status; -unadjusted age, smoking and drinking status. *P<0.05. Abbreviations: HR, hazard ratio; IRR, incident rate ratios; BMI, body mass index. Considering that significant lung diseases might affect our findings, we further excluded participants who self-reported COPD and bronchiectasis at follow-up (n=184). The excluded data were also included in the Poisson regression model and the Cox proportional hazards model for analysis. We found that the results were not affected after excluding patients' self-reported COPD and bronchiectasis in women () and men ().

Discussion

This prospective, open cohort study was conducted in China using data from multiple health management centres. The results of the specific health examinations suggested that overweight and/or obesity was arisk factor for incident asthma among only women, not men. However, there was no significant correlation between metabolic syndrome and incident asthma in either men or women. These findings, based on alongitudinal analysis of alarge adult population data set, confirm the importance of overweight and/or obesity as arisk factor for incident asthma in adult women. In recent years, findings on metabolic syndrome and asthma have been inconsistent. Studies in the US, Norway, and South Korea have shown that metabolic syndrome is associated with incident asthma.20,22,23 However, among these studies, the large retrospective cohort study from Norway showed that high WC (adjusted OR 1.62, 95% CI 1.36–1.94) and elevated glucose or diabetes (adjusted OR 1.43, 95% CI 1.01–2.04) were associated with an increased risk of incident asthma in adults. In addition, acohort followed for over 25 years in the USA reported that after adjusting for BMI, the correlation between metabolic syndrome and asthma attacks was no longer statistically significant among women (P= 0.44). Interestingly, aretrospective cohort study in Japan showed that obesity, not metabolic syndrome, was asignificant risk factor for the incidence of late-onset asthma but only in middle-aged Japanese women,21 which was similar to the result of our open cohort study. Our observations suggest that overweight and/or obesity, not metabolic syndrome, is asignificant risk factor for incident asthma, but only in Chinese women, not in men. The inconsistency between the findings of previous studies and our current study may be due to the differences in study designs, populations and diagnostic criteria for metabolic syndrome. We need to carefully interpret the results for the components, as these components in the definition of metabolic syndrome are dichotomous and do not allow for adjustment.13 In our study, TGs were statistically significant in univariate analysis among women (P=0.037). However, the association was no longer statistically significant after adjustment for covariates (P>0.050). Further studies should address the individual component in more detail; for example, repeated measurements of consecutive serum levels in acohort study should be performed to eliminate confounding factors and help identify the associations of the components of metabolic syndrome with asthma. There are several possible mechanisms connecting overweight and/or obesity and incident asthma. We observed that obesity may change pulmonary physiology and lung function in adults.28,29 Excessive accumulation of fat in the chest and abdomen might cause compression of the lungs, accompanied by reduced lung volume. In fact, we have shown that obesity increased the folding of the surrounding airways and parenchyma, especially in asthmatic patients with late-onset disease.30 In addition, adipocytokines (leptin and resistin) produced by adipose tissue have been suggested to promote systemic inflammation, which may induce asthma.31,32 Patients with aBMI≥25kg/m2 showed higher levels of leptin, and this cytokine difference was also found in female patients with asthma (P <0.05).33 On the other hand, asthma and obesity have considerable genetic components. The obesity–asthma association may also be due to common genes shared by both obesity and asthma. Candidate gene studies have reported afew genes associated with asthma and obesity, such as PRKCA and NR3C1.34,35 The specific mechanism of the relationship between overweight and/or obesity and asthma still needs more research to explore. There were some limitations to our study. First, this study lacks demographic characteristics such as birthplace, residence, occupation, marriage, income, etc. This may be due to the incomplete basic information filled out by the research subjects in various medical examination centers, which may have acertain impact on the results. Second, the measurement of various indicators of metabolic syndrome over time was not included, as some study subjects did not participate in regular physical examinations. Third, the doctor diagnosed asthma based on the patient ’s lung function indicators and clinical manifestations, but we did not collect data on the lung function indicators, which may affect the research results to acertain extent. Fourth, metabolic syndrome was diagnosed using the diagnostic criteria recommended by the CDS in 2004; however, it did not include WC, which may not reflect overweight and/or obesity, as many studies have shown that WC was closely related to asthma.36–38 Therefore, we hope that the diagnostic criteria for metabolic syndrome will be updated in China. In conclusion, the study confirmed overweight and/or obesity as arisk factor for incident asthma only among women, not men. However, our study suggested that metabolic syndrome was not significantly associated with incident asthma in both women and men. The findings of this study warrant further research, particularly addressing the associations between the components of metabolic syndrome and incident asthma in prospective studies.
  33 in total

Review 1.  Risk factors for asthma: is prevention possible?

Authors:  Richard Beasley; Alex Semprini; Edwin A Mitchell
Journal:  Lancet       Date:  2015-09-12       Impact factor: 79.321

Review 2.  Obesity and asthma.

Authors:  Ubong Peters; Anne E Dixon; Erick Forno
Journal:  J Allergy Clin Immunol       Date:  2018-04       Impact factor: 10.793

Review 3.  Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review.

Authors:  Zarqa Ali; Charlotte Suppli Ulrik; Tove Agner; Simon Francis Thomsen
Journal:  Dermatology       Date:  2018-08-15       Impact factor: 5.366

Review 4.  Epidemiology of Asthma and Influence of Ethnicity.

Authors:  Theo J Moraes; Malcolm R Sears; Padmaja Subbarao
Journal:  Semin Respir Crit Care Med       Date:  2018-02-10       Impact factor: 3.119

5.  Obesity, but not metabolic syndrome, as a risk factor for late-onset asthma in Japanese women.

Authors:  Yasuhiro Tomita; Yuma Fukutomi; Mari Irie; Kazuhiro Azekawa; Hiroaki Hayashi; Yosuke Kamide; Kiyoshi Sekiya; Yoichi Nakamura; Chiharu Okada; Terufumi Shimoda; Yoshinori Hasegawa; Masami Taniguchi
Journal:  Allergol Int       Date:  2018-11-23       Impact factor: 5.836

6.  Prevalence and incidence of asthma related to waist circumference and BMI in a Swedish community sample.

Authors:  Ulla Nyström Kronander; Melcher Falkenberg; Olle Zetterström
Journal:  Respir Med       Date:  2004-11       Impact factor: 3.415

Review 7.  Metabolic syndrome: from the genetics to the pathophysiology.

Authors:  Silvia Sookoian; Carlos J Pirola
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

8.  Overweight and obesity as risk factors for impaired lung function in patients with asthma: A real-life experience.

Authors:  Giorgio Ciprandi; Irene Schiavetti; Rossana Bellezza Fontana; Valentina Sorbello; Fabio L M Ricciardolo
Journal:  Allergy Asthma Proc       Date:  2014 Jul-Aug       Impact factor: 2.587

9.  Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet Respir Med       Date:  2017-08-16       Impact factor: 30.700

Review 10.  Adiponectin, Leptin, and Resistin in Asthma: Basic Mechanisms through Population Studies.

Authors:  Akshay Sood; Stephanie A Shore
Journal:  J Allergy (Cairo)       Date:  2013-10-30
View more
  1 in total

1.  An Elevated METS-IR Index Is Associated With Higher Asthma Morbidity and Earlier Age of First Asthma in US Adults: Results Based on a Cross-Sectional Study.

Authors:  Yan Chen; Junping Yang; Kexing Han; Yan Wang; Cuixia Zhuang; Laxiang Zhu; Mingwei Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.